• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,584.84 71.29
(0.14%)
Dow Jones
7,519.91 78.81
(1.06%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,394.87 -113.74
(-1.08%)
Forex
USD-INR
94.51 -0.04
(-0.04%)
EUR-INR
109.43 -0.23
(-0.21%)
GBP-INR
126.51 -0.33
(-0.26%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
39.46
975.13
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.06
 

sanmit infra ltd
NBCC bids successfully to acquire 279,989 sq. ft. (super built-up area) at Bharat Business Park, New Delhi
Apr 17,2026
The board of NBCC (India) has approved the proposal for participation in an e-auction process for purchase of a commercial tower admeasuring approximately 279,989 sq. ft. (super built-up area) at Bharat Business Park, Sarojini Nagar, New Delhi, for the purposes of self-use, leasing and/or investment.

Accordingly, the Company participated in the said e-auction held on 16 April 2026, and emerged as the Highest Bidder. The total estimated investment towards the proposed purchase would be approximately Rs 1,374.45 crore, payable in stages on construction-linked basis, in accordance with the progress of construction and subject to the terms and conditions of the e-auction.